bf/NASDAQ:GRNA_icon.jpeg

NASDAQ:GRNA

GreenLight Biosciences Holdings

  • Stock

USD

Last Close

0.30

21/07 20:00

Market Cap

45.43M

Beta: 1.45

Volume Today

143.17K

Avg: 385.14K

PE Ratio

−0.29

PFCF: −0.31

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '20
Mar '21
Jun '21
Sep '21
Dec '21
Mar '22
Jun '22
Sep '22
Dec '22
Mar '23
net income
-17.49M
-
-21.28M
21.70%
-27.17M
27.68%
-29.18M
7.39%
62.58M
314.45%
-38.21M
161.05%
-51.93M
35.91%
-38.16M
26.51%
-38.76M
1.59%
-28.47M
26.56%
depreciation and amortization
618K
-
1.11M
80.10%
1.19M
6.83%
1.37M
15.48%
2.10M
-
2.02M
3.44%
1.76M
13.19%
2.20M
25.16%
2.33M
6.14%
deferred income tax
-1K
-
-6K
500%
201K
3,450%
1.14M
468.66%
stock based compensation
217K
-
348K
60.37%
407K
16.95%
537K
31.94%
2.19M
-
1.63M
25.29%
2.70M
65.24%
2.32M
14.15%
2.31M
0.43%
change in working capital
-271K
-
-1.74M
542.07%
4.22M
342.70%
871K
79.37%
7.88M
805.05%
-16.23M
305.87%
26.76M
264.90%
-7.00M
126.17%
4.88M
169.64%
-8.15M
267.03%
accounts receivables
-5M
-
-5M
0%
15M
-
inventory
accounts payables
-16K
-
-272K
1,600%
4.24M
1,658.46%
-2.69M
163.48%
-1.95M
-
-1.03M
47.39%
-1.02M
0.39%
-2.61M
155.13%
233K
108.93%
other working capital
-255K
-
-1.47M
475.69%
-16K
98.91%
3.56M
22,362.50%
-9.28M
-
32.79M
453.43%
-5.98M
118.24%
-7.51M
25.64%
-8.38M
11.53%
other non cash items
296K
-
204K
31.08%
413K
102.45%
1.46M
253.27%
-5.03M
444.67%
685K
113.62%
-1.19M
273.72%
727K
161.09%
4.78M
557.63%
913K
80.90%
net cash provided by operating activities
-16.63M
-
-21.36M
28.45%
-20.94M
1.95%
-24.94M
19.10%
65.43M
362.35%
-49.47M
175.60%
-22.70M
54.12%
-39.98M
76.13%
-24.59M
38.49%
-31.06M
26.32%
investments in property plant and equipment
-2.54M
-
-4.69M
84.20%
-2.10M
55.25%
-4.58M
118.11%
-287K
-
-12.58M
4,284.32%
-10.07M
19.94%
-3.60M
64.23%
-1.61M
55.37%
acquisitions net
purchases of investments
sales maturities of investments
other investing activites
37K
-
net cash used for investing activites
-2.54M
-
-4.69M
84.20%
-2.10M
55.25%
-4.58M
118.11%
-195.64M
4,175.31%
-250K
99.87%
-12.58M
4,933.20%
-10.07M
19.94%
-3.60M
64.23%
-1.61M
55.37%
debt repayment
-110K
-
-175K
59.09%
-415K
137.14%
-968K
133.25%
-1.26M
29.96%
-975K
22.50%
-2.08M
113.74%
-2.07M
0.67%
-2.10M
1.40%
-3.02M
44.07%
common stock issued
106.34M
-
-310K
100.29%
common stock repurchased
dividends paid
other financing activites
-301K
-
2.81M
1,033.22%
4.23M
50.44%
12.90M
205.23%
189.08M
1,365.89%
103.43M
45.30%
-1.73M
101.67%
3K
100.17%
345K
11,400%
35K
89.86%
net cash used provided by financing activities
-191K
-
2.63M
1,479.06%
3.81M
44.68%
11.93M
213.07%
190.34M
1,495.36%
102.45M
46.17%
-3.81M
103.72%
104.27M
2,836.08%
-2.06M
101.98%
-2.99M
44.82%
effect of forex changes on cash
net change in cash
-19.36M
-
-23.41M
20.90%
-19.23M
17.87%
-17.59M
8.54%
-34.85M
98.19%
52.74M
251.31%
-39.09M
174.13%
54.22M
238.70%
-30.26M
155.80%
-35.66M
17.85%
cash at beginning of period
114.51M
-
95.15M
16.91%
71.74M
24.61%
52.51M
26.81%
34.92M
33.49%
31.81M
8.91%
84.54M
165.79%
45.45M
46.24%
99.67M
119.29%
69.42M
30.35%
cash at end of period
95.15M
-
71.74M
24.61%
52.51M
26.81%
34.92M
33.49%
67.50K
99.81%
84.54M
125,157.79%
45.45M
46.24%
99.67M
119.29%
69.42M
30.35%
33.76M
51.37%
operating cash flow
-16.63M
-
-21.36M
28.45%
-20.94M
1.95%
-24.94M
19.10%
65.43M
362.35%
-49.47M
175.60%
-22.70M
54.12%
-39.98M
76.13%
-24.59M
38.49%
-31.06M
26.32%
capital expenditure
-2.54M
-
-4.69M
84.20%
-2.10M
55.25%
-4.58M
118.11%
-287K
-
-12.58M
4,284.32%
-10.07M
19.94%
-3.60M
64.23%
-1.61M
55.37%
free cash flow
-19.17M
-
-26.05M
35.85%
-23.04M
11.54%
-29.52M
28.11%
65.43M
321.68%
-49.76M
176.04%
-35.28M
29.09%
-50.05M
41.87%
-28.19M
43.67%
-32.67M
15.88%

All numbers in USD (except ratios and percentages)